Psychedelics 101
A comprehensive introduction to psychedelic substances, their history, and current research.
Learn MoreAdvancing the Science of Psychedelics for Personal Growth. Metanoia investigates how psychedelics may support the well being of healthy individuals and empower them to thrive and reach their full potential
To advance the scientific understanding of psychedelics and their potential to enhance personal growth, creativity, and well-being in healthy individuals. We are committed to conducting rigorous, ethical research that expands knowledge of how these compounds can support human flourishing beyond clinical applications.
A world where the transformative potential of psychedelics is fully understood and responsibly harnessed—empowering individuals to achieve greater self-awareness, creativity, and emotional resilience, while fostering a deeper connection to themselves and others.
Understanding the challenges and opportunities in psychedelic research
Depression and anxiety rates among young adults have increased by more than 60%.
Most clinical psychedelic studies focus on mental health or addictive disorders; far fewer explore wellness and growth in healthy individuals.
The self-improvement industry is booming, and demand is growing for guided experiences aimed at enhancing well-being, creativity, awareness and resilience.
A critical lack of qualified oversight for personal-growth-focused sessions raises safety and ethical concerns.
The field suffers from fragmented knowledge and insufficient integration across neuroscience, genetics, chemistry and evidence-based therapeutic practices.
Metanoia - a California based nonprofit organization with a for-profit subsidiary dedicated to science‑based education and psychedelics multidisciplinary research integrating neuroscience, genetics, chemistry and therapeutic practices to help healthy individuals thrive and reach their full potential
Psychedelics are sustainable, trusted by many and rooted in centuries of traditional use. These natural substances contain diverse psychoactive compounds with unique profiles and biosynthetic pathways.
Psychedelics are complex and so is the science behind them. Metanoia unites genetics, chemistry, neuroscience, cultivation and therapeutic practices to understand how these compounds influence the brain, mood and human potential. This holistic approach moves beyond conventional therapy, exploring how psychedelics might foster creativity, resilience, empathy and personal growth.
Metanoia examines how psychedelics such as psilocybin, LSD, MDMA and ketamine may ignite creativity and insight, promote emotional well being and deepen empathy and social connection. These experiences can shift perception and self awareness; while research on attention and logical cognition remains mixed, responsibly guided use may support mood, resilience and personal growth.
Unlocking creative potential and novel thinking patterns
Enhancing analytical and innovative problem-solving abilities
Understanding effects on cognitive processes and mental flexibility
Exploring impacts on learning capacity and memory formation
Building capacity to navigate challenges and recover from setbacks
Deepening interpersonal bonds and community belonging
Examining shifts in sensory experience and reality perception
Heightening present-moment awareness and mindfulness
Promoting positive emotional states and mental wellness
Strengthening intimate and meaningful relationships
Cultivating deeper understanding and compassion for others
Developing deeper insight into oneself and personal patterns
Our mission guides everything we do: a California based nonprofit broadens access to resources and ensures public benefit, while for profit subsidiary undertakes research and revenue generating activities with the flexibility, competitive compensation and sustainability needed to attract top talent and maximize impact
501(c)(3) Organization
Collaborative Partnership
Israel-Based Operations
The principles that guide our research and practice
Metanoia translates the latest research into accessible guidance
Safety and ethics are our compass -- no illegal facilitation, just honest information
Our focus is on helping healthy adults use knowledge to grow, create, and connect by Psychedelics for their daily life's challenges and growth.
Metanoia operates with open books and open minds -- from publishing our progress to earning your trust
From Foundation to Full Scale Research
A comprehensive introduction to psychedelic substances, their history, and current research.
Learn MoreBest practices for set, setting, harm reduction, and integrating psychedelic experiences.
Read GuideUnderstanding the legal landscape and ethical considerations of psychedelics.
ExploreHow psychedelics may enhance creative thinking and innovative problem-solving.
DiscoverResearch on psychedelics' impact on mood, resilience, and mental health.
Learn MoreExploring how psychedelics can deepen social connection and empathic understanding.
Read MoreMetanoia is governed by a Board of Directors that oversees our mission and finances. We follow nonprofit best practices in accountability, including a conflict of interest policy and a strict prohibition on political campaigning under 501(c)(3) rules. We adhere to all relevant research and fundraising laws, emphasize transparency and will publish annual impact and financial reports. Key documents are available on our website.
Metanoia is committed to the highest ethical standards in all aspects of our work. We adhere to internationally recognized research guidelines and implement rigorous safety protocols to protect participants and ensure the integrity of our studies. All research is reviewed and approved by independent ethics committees and institutional review boards. Participation is fully voluntary and based on informed consent; individuals receive clear information about potential risks and benefits and may withdraw at any time. We screen participants carefully and ensure that sessions are conducted by qualified professionals in safe, supportive environments with appropriate medical oversight. Risk‑mitigation procedures, integration support and emergency protocols are in place to address potential adverse effects. We respect cultural traditions surrounding psychedelic use and work to prevent exploitation of indigenous knowledge. All data are handled confidentially in compliance with privacy laws, and results are reported transparently to the scientific community and the public. By upholding these principles, we aim to advance knowledge responsibly while prioritizing participant safety and well‑being.
Shraga Israel, M.Sc
Founder of Metanoia
Proudly aligned with global standards in research ethics
Metanoia B20250117682
Address: 2108 N ST, Sacramento, CA 95816, USA
Phone: +1 (916) 282-3179
Employer Identification Number: 39-2328100
501(c)(3) status update: Currently pending IRS approval.
Metanoia blends entrepreneurial strategies with a commitment to social impact
Join us in pioneering research that could unlock new dimensions of creativity, self-awareness, and personal growth.